Chemoprophylaxis of Tuberculosis: When Is the Benefit Worth the Risk and Cost?
- 1 May 1971
- journal article
- clinical trial
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 74 (5) , 761-768
- https://doi.org/10.7326/0003-4819-74-5-761
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Identifying the Tuberculous InfectedPublished by American Medical Association (AMA) ,1968
- The epidemiology of drug‐induced systemic lupus erythematosusArthritis & Rheumatism, 1967
- ISONIAZID: HOW MUCH A CARCINOGEN ?The Lancet, 1967
- POSSIBLE INDUCTION OF ANTINUCLEAR ANTIBODIES BY ISONIAZIDThe Lancet, 1966
- Drug-Induced Lupus-Like SyndromeArchives of internal medicine (1960), 1963
- Isoniazid jaundice and its relationship to iproniazid jaundiceTubercle, 1962
- Hypersensitivity Reaction to Antituberculosa Drugs with Hepatitis, Lupus Phenomenon and Myocardial InfarctionNew England Journal of Medicine, 1961
- Fatal Hepatic Necrosis Secondary to Isoniazid TherapyPublished by American Medical Association (AMA) ,1961
- The relationship of tuberculosis to the development of massive pneumokoniosis in coal workersBritish Journal of Tuberculosis and Diseases of the Chest, 1954
- Deleterious Effect of ACTH and Cortisone on TuberculosisNew England Journal of Medicine, 1951